Podcast

January 8, 2025

170 – The #1 Secret to Understanding ISO 13485 (You’ll Wish You Knew Sooner)

By viewing ISO 13485 through the lens of interconnected Plan-Do-Check-Act (PDCA) cycles, Subhi offers a fresh perspective that simplifies the implementation of this quality management standard. He explains the structure

January 1, 2025

169 – Should You Study Bioengineering in 2025? My Decade-Long Perspective

In this episode, Subhi Saadeh, a seasoned professional in the pharma and medical device industry, shares his insights on whether choosing bioengineering is the right career path. Drawing from his

December 25, 2024

168 – Audits, Audits, Audits: Why They Matter in Pharma, Medical Devices, and Personal Growth

In this episode of Let's Combinate, host Subhi Saadeh discusses the significance of audits as a key appraisal activity and draws parallels with personal self-assessment inspired by Peter Drucker's book,

December 18, 2024

167 – Smart Pills, Digital Drug Delivery Systems, and How Technology is Reshaping Pharma and Healthcare with Timothy Aungst

In this episode of Let's Combinate, host Subhi Saadeh dives into the world of digital transformation in healthcare with Dr. Timothy Aungst, a visionary pharmacist and digital health expert. Dr.

December 11, 2024

166 – Sync or Sink: 3 Levels of Harmonization for Combination Product Success

Subhi proposes a broader definition of harmonization, not just aligning regulations but also fostering synergy among drug and device teams. Subhi emphasizes the importance of creating seamless ecosystems for operational

December 4, 2024

165 – Anatomy of a Target Product Profile(TPP): All 10 Sections EXPLAINED with Marta New

In this episode of Let's Combinate, host Subhi Sadeh is joined by Marta New, CEO of Radyus Research, to discuss the importance of Target Product Profiles (TPPs) in drug development

November 27, 2024

164 – Tiny Particles, Big Impact: Breaking down USP 788 & USP 790

In this episode, Subhi Saadeh delves into the specifics of USP chapters 788 and 790, which focus on the testing and acceptance criteria for sub-visible and visible particles in injectable

November 20, 2024

163 – ICH Q12, Established Conditions, Post-Approval Changes, PACMP’s, and the Pharma Lifecycle

In this episode of Let's Combinate, host Subhi Saadeh delves into the significance of ICH Q12 for the pharmaceutical industry, especially concerning established conditions and drug-device combination products. Subhi explains

November 12, 2024

162 – Philip Crosby’s 5 Bad Beliefs About Quality (And How to Avoid Them)

In this episode, Subhi delves into 'Quality is Free' by Philip Crosby, a seminal book in quality management. Highlighting its personal significance, the host discusses the core concept that quality,

November 6, 2024

161 – ISO 14971 and ICH Q9 EXPLAINED: Risk Management Frameworks in Medical Devices, Pharma and Combination Products

In this episode of Let's Combinate, host Subhi Saadeh explores the essential frameworks of risk management in medical devices and pharmaceuticals: ISO 14971 and ICH Q9. He discusses the origins,

October 30, 2024

160 – Drug Tech Transfer vs. Device Design Transfer EXPLAINED!

In this episode of *Let's Combinate*, Subhi delves into the critical distinctions between drug tech transfer and device design transfer, especially pertinent to combination products. Sue comprehensively outlines the regulatory

October 23, 2024

159 – Centralized, Decentralized & Federated Quality Models, McKinsey Study, and QA vs. QC with Ben Locwin

In this informative episode of Let's Combinate, host Subhi Saadeh and frequent guest Ben delve into the key aspects of quality management across various organizational structures. Through their engaging discussion,

Join Our newsletter

Sign up now to stay ahead with our combo product tips and never miss a weekly episode!

By signing up, you agree to receive email from this website.